N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.
Chen Y, Lu Z, Qi C, Yu C, Li Y, Huan W, Wang R, Luo W, Shen D, Ding L, Ren L, Xie H, Xue D, Wang M, Ni K, Xia L, Qian J, Li G.
Chen Y, et al. Among authors: wang m, wang r.
Mol Cancer. 2022 May 10;21(1):111. doi: 10.1186/s12943-022-01549-1.
Mol Cancer. 2022.
PMID: 35538475
Free PMC article.